References
- GooderhamMJPoulin-CostelloMSheltonJBayanNPappKAPredictors of topical use in psoriasis patients in the REFINE StudyJ Cutan Med Surg201620210611226330052
- ParisiRSymmonsDPMGriffithsCEMGlobal epidemiology of psoriasis: a systematic review of incidence and prevalenceJ Invest Dermatol201313337738523014338
- CohenBEMartiresKJHoRSPsoriasis and the risk of depression in the US population: National Health and Nutrition Examination Survey 2009–2012JAMA Dermatol20161521737926421371
- HuertaCRiveroERodríguezLAIncidence and risk factors for psoriasis in the general populationArch Dermatol2007143121559156518087008
- BoehnckeWHEtiology and pathogenesis of psoriasisRheum Dis Clin North Am201541466567526476225
- KapoorCVaidyaSWadhwanVHiteshKaurGPathakASeesaw of matrix metalloproteinases (MMPs)J Cancer Res Ther2016121283527072206
- ShayGLynchCCFingletonBMoving targets: emerging roles for MMPs in cancer progression and metastasisMatrix Biol201544–46200206
- MezentsevANikolaevABruskinSMatrix metalloproteinases and their role in psoriasisGene2014540111024518811
- ArpinoVBrockMGillSEThe role of TIMPs in regulation of extracellular matrix proteolysisMatrix Biol201544–46247254
- SartakhtiJSManshaeiMHSadeghiMMMP-TIMP Interactions in cancer invasion: an evolutionary game-theoretical frameworkJ Theor Biol2017412172627670802
- RaczEPrensEPPhototherapy and photochemotherapy for psoriasisDermatol Clin2015331798925412785
- FredrikssonTPetterssonUSevere psoriasis oral therapy with a new retinoidDermatologica19781574238244357213
- GallieraETacchiniLCorsiRomanelliMMMatrix metalloproteinases as biomarkers of disease: updates and new insightsClin Chem Lab Med201553334935525153404
- ŁawickiSZajkowskaMGłażewskaEKBedkowskaGESzmitkowskiMPlasma levels and diagnostic utility of VEGF, MMP-9, and TIMP-1 in the diagnosis of patients with breast cancerOnco Targets Ther2016991191926966379
- ŁawickiSGłażewskaEKSobolewskaMBedkowskaGESzmitkowskiMPlasma levels and diagnostic utility of macrophage colony-stimulating factor, matrix metalloproteinase-9, and tissue inhibitor of metalloproteinases-1 as new biomarkers of breast cancerAnn Lab Med201636322322926915610
- McCawleyLJMatrisianLMMatrix metalloproteinases: they’re not just for matrix anymore!Curr Opin Cell Biol200113553454011544020
- NagaseHVisseRMurphyGStructure and function of matrix metalloproteinases and TIMPsCardiovasc Res200669356257316405877
- Ayala-FontánezNSolerDCMcCormickTSCurrent knowledge on psoriasis and autoimmune diseasesPsoriasis Targets Ther20166732
- HeidenreichRRöckenMGhoreschiKAngiogenesis drives psoriasis pathogenesisInt J ExpPathol2009903232248
- EysteinsdóttirJHSigurgeirssonBÓlafssonJHTherole of Th17/Tc17peripheral blood T cells in psoriasis and their positive therapeutic responseScand J Immunol201378652953724111693
- AltrichterSBoodsteinNMaurerMMatrix metalloproteinase-9: a novel biomarker for monitoring disease activity in patients with chronic urticaria patients?Allergy200964465265619317840
- SigurdardottirGEkmanAKStåhleMBivikCEnerbackCSystemic treatment and narrowband ultraviolet B differentially affect cardiovascular risk markers in psoriasisJ Am Acad Dermatol20147061067107524656729
- FleischmajerRKurodaKHazanRBasement membrane alterations in psoriasis are accompanied by epidermal overexpression of MMP-2 and its inhibitor TIMP-2J Invest Dermatol2000115577177711069613
- SimonettiOLucariniGGoteriGVEGF is likely a key factor in the link between inflammation and angiogenesis in psoriasis: results of an immunohistochemical studyInt J Immunopathol Pharmacol200619475176017166397
- ChandranYCookRJEdwinJSoluble biomarkers differentiate patients with psoriatic arthritis from those with psoriasis without arthritisRheumatology (Oxford)20104971399140520421218
- ReissMJHanYPGarciaEMatrix metalloproteinase-9 delays wound healing in a murine wound modelSurgery201014729530220004432
- BullardKMLundLMudgettJSImpaired wound contraction in stromelysin-1-deficient miceAnn Surg1999230226026510450741
- GłażewskaEKNiczyporukMPrzylipiakAInfluence of narrowband ultraviolet-B phototherapy on plasma concentration of matrix metalloproteinase – 12 In psoriatic patientsPostep Derm AlergolIn press2017
- GłażewskaEKNiczyporukMŁawickiSTherapy Of Psoriasis With Narrowband Ultraviolet-B Light Influences Plasma Concentration Of MMP-2 And Timp-2 In PatientsTher Clin Risk Manag2016121579158527799779
- FlisiakIPorebskiPChodynickaBEffect of psoriasis activity on metalloproteinase-1 and tissue inhibitor of metalloproteinase-1 in plasma and lesional scalesActa Derm Venereol2006861172116585983
- ReichAMędrekKEffects of narrow band UVB (311 nm) irradiation on epidermal cellsInt J Mol Sci20131448456846623594996
- RáczEPrensEPKurekDEffective treatment of psoriasis with narrow-band UVB phototherapy is linked to suppression of the IFN and Th17 pathwaysJ Invest Dermatol201113171547155821412260
- RichardEGHönigsmannHPhototherapy, psoriasis, and the age of biologicsPhotodermatol Photoimmunol Photomed20143013724313462
- BuomminoEDe FilippisAGaudielloFModification of osteopontin and MMP-9 levels in patients with psoriasis on anti-TNF-alpha therapyArch Dermatol Res2012304648148522684781
- FuMinLXueWXiLingDAction mechanism of narrow-band ultraviolet B on vascular regulatory factors in psoriasis vulgarisChin J Dermatol200942163166